AC Immune COO Holds 140K Shares, Boosting Insider Confidence in Neuro‑Diagnostic Pipeline
AC Immune insider confidence signals a stable outlook; COO’s substantial stake and positive Phase 1 PET tracer data suggest potential upside for investors.
4 minutes to read